Cargando…
The TRIPS Agreement implementation in Brazil : patents in the pharmaceutical area /
Brazil's insertion into the World Trade Organization (WTO) has stimulated economic growth, as the country has been benefiting from lower trade barriers. The country has accepted the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) - Annex 1C of the WTO agreement - whic...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Baden-Baden, Germany : Augsburg :
Nomos ; MIPLC, Munich Intellectual Property Law Center,
2015.
|
| Edición: | 1. edition. |
| Colección: | MIPLC studies ;
v. 25. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a22000003i 4500 | ||
|---|---|---|---|
| 001 | JSTOROA_ocn922456973 | ||
| 003 | OCoLC | ||
| 005 | 20231005004200.0 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 150928t20152015gw ob 000 0 eng d | ||
| 040 | |a YDXCP |b eng |e pn |c YDXCP |d OCLCO |d OCLCF |d OCLCO |d OCLCQ |d EBLCP |d OCLCQ |d IDB |d MERUC |d OCLCQ |d OCLCO |d OCLCA |d EZ9 |d OCLCQ |d OCLCO |d JSTOR |d ICN |d SOI |d ERL |d TXR |d OCLCQ |d C6I |d EQF |d OCLCQ |d UKKNU |d OCLCO |d OCLCQ |d OCLCO | ||
| 020 | |a 9783845259628 |q (electronic bk.) | ||
| 020 | |a 3845259620 |q (electronic bk.) | ||
| 020 | |z 9783848718979 | ||
| 020 | |z 3848718979 | ||
| 029 | 1 | |a AU@ |b 000064562642 | |
| 029 | 1 | |a AU@ |b 000065197288 | |
| 035 | |a (OCoLC)922456973 | ||
| 037 | |a 22573/ctv932s4j |b JSTOR | ||
| 043 | |a s-bl--- | ||
| 050 | 4 | |a KHD1639 |b .T75 2015eb | |
| 072 | 7 | |a K |2 lcco | |
| 072 | 7 | |a RA |2 lcco | |
| 072 | 7 | |a LAW |x 014000 |2 bisacsh | |
| 082 | 0 | 4 | |a 340 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Kunisawa, Viviane Yumy Mitsuuchi, |e author. | |
| 245 | 1 | 4 | |a The TRIPS Agreement implementation in Brazil : |b patents in the pharmaceutical area / |c Viviane Yumy Mitsuuchi Kunisawa. |
| 246 | 3 | |a Trade-Related Aspects of Intellectual Property Rights Agreement implementation in Brazil | |
| 250 | |a 1. edition. | ||
| 264 | 1 | |a Baden-Baden, Germany : |b Nomos ; |a Augsburg : |b MIPLC, Munich Intellectual Property Law Center, |c 2015. | |
| 264 | 4 | |c ©2015 | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file | ||
| 490 | 1 | |a MIPLC studies ; |v volume 25 | |
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a Cover; I. CHAPTER. INTRODUCTION; II. CHAPTER. THE FRAMEWORK OF TRIPS; III. CHAPTER. THE BRAZILIAN PATENT SYSTEM; IV. CHAPTER. ANALYZING THE BRAZIL CASE; V. CHAPTER. CONCLUDING REMARKS; ANNEX: Law 9279, of May 14, 1996; Bibliography; A. Brazilian context prior to TRIPS; B. TRIPS Agreement; C. Remarks on the Applicability of TRIPS in Brazil; A. Overview; B. Patents on Pharmaceuticals; C. Provisions on Compulsory License; A. General Overview: Brazilian statistics and the public healthcare system; B. AIDS in Brazil; C. The Cases of Kaletra and Efavirenz | |
| 505 | 8 | |a D. Impacts of the WTO Free Trading System on BrazilI. Books, Articles, Manuscripts and Other Documents; II. International Treaties / National Legislation; III. Cases; 1. General Principles; 2. TRIPS Provisions on Patent Law; 3. The Pharmaceutical Industry Context; 1. The Constitutional Clause; 2. General Provisions on Patentability; 3. Term of Protection and Rights Conferred by Patents; 1. The Prior Consent Requirement; 2. Second Medical Use Inventions; 1. Previous Law; 2. Provisions of Law 9279/1996; 1) Statistics; 2) The Anti-AIDS Program | |
| 505 | 8 | |a 1. The Panel Against the US for Cotton Subsidies2. Remarks on the Overall Pharmaceutical Scenario; 2.1. Patentable Subject Matter and Conditions on Patent Applicants; 2.2. Rights Conferred and Term of Protection; 2.3. Flexibilities within TRIPS concerning Patents; 2.4. Other Provisions; 3.1. The Doha Declaration on the TRIPS Agreement and Public Health; 3.2. The Decision Implementing Paragraph 6 of the Doha Declaration; 1.1) Introduction of Article 229-C in the Patent Statute and Competence of the ANVISA | |
| 505 | 8 | |a 2.1) INPI Examination Guidelines, ANVISA Policies and Debates on New Examination Guidelines2.2) Discussions in Congress and Court Decisions; 2.3) Further Remarks; 2.1) Abuse of Economic Power and Lack of Local Exploitation; 2.2) Dependent Patents; 2.3) Procedural Aspects; 2.4) Cases of National Emergency or Public Interest; 1.1. Cross-retaliation on IP rights; 1.2. Ongoing Discussions; 2.3.1. Rules on Implementation and Protection of Existing Subject Matter; 2.3.2. Exclusions from Patentable Subject Matter; 2.3.3. Exhaustion and Parallel Importation | |
| 505 | 8 | |a 2.3.4. General Exception Rules2.3.5. Compulsory Licenses; 2.1.1) Abusive Exercise of Rights or Abuse of Economic Power; 2.1.2) Insufficient or Non-Exploitation in Brazilian Territory; 2.1.3) Economic Capacity of the Licensee and the Importation Exception; 2.1.2.1) Analysis under TRIPS; 2.1.2.2) The Panel filed by the USA before the WTO | |
| 520 | |a Brazil's insertion into the World Trade Organization (WTO) has stimulated economic growth, as the country has been benefiting from lower trade barriers. The country has accepted the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) - Annex 1C of the WTO agreement - which sets out minimum standards of protection for Intellectual Property (IP) rights. Law No. 9,279, of May 14, 1996 was enacted to comply with TRIPS, suppressed restrictions to patentable subject matter, allowing patents in the pharmaceutical field. The granting of compulsory licenses as one of the flexibilities to patent rights provided in TRIPS and in the Brazilian law plays an important role in the governmental program of free distribution of drugs for the treatment of AIDS, evidencing the complex relationship between private and public interests. This study has been conducted with use of bibliographical method, providing for an analysis of the Brazilian patent law within the framework provided by TRIPS. The provisions on patents in the pharmaceutical area and compulsory license have been chosen to serve as the main driver for such analysis. Viviane Yumy Mitsuuchi Kunisawa is a Brazilian attorney specialized in IP Law. | ||
| 590 | |a JSTOR |b Books at JSTOR All Purchased | ||
| 590 | |a JSTOR |b Books at JSTOR Open Access | ||
| 630 | 0 | 0 | |a Agreement on Trade-Related Aspects of Intellectual Property Rights |d (1994 April 15) |
| 630 | 0 | 7 | |a Agreement on Trade-Related Aspects of Intellectual Property Rights (1994 April 15) |2 fast |
| 650 | 0 | |a Patent medicines |x Law and legislation |z Brazil. | |
| 650 | 0 | |a Drugs |z Brazil |x Patents. | |
| 650 | 6 | |a Médicaments |z Brésil |x Brevets d'invention. | |
| 650 | 7 | |a LAW |x Commercial |x General. |2 bisacsh | |
| 650 | 7 | |a Drugs |2 fast | |
| 650 | 7 | |a Patent medicines |x Law and legislation |2 fast | |
| 651 | 7 | |a Brazil |2 fast | |
| 655 | 7 | |a Patents |2 fast | |
| 776 | 0 | 8 | |i Print version: |a Kunisawa, Viviane Yumy Mitsuuchi. |t TRIPS Agreement implementation in Brazil. |b 1. edition. |d Baden-Baden, Germany : Nomos ; Augsburg : MIPLC, Munich Intellectual Property Law Center, 2015 |z 9783848718979 |z 3848718979 |w (OCoLC)910512051 |
| 830 | 0 | |a MIPLC studies ; |v v. 25. | |
| 856 | 4 | 0 | |u https://jstor.uam.elogim.com/stable/10.2307/j.ctv941vp4 |z Texto completo |
| 938 | |a EBL - Ebook Library |b EBLB |n EBL4350253 | ||
| 938 | |a Knowledge Unlatched |b KNOW |n 96bf2012-93c1-49be-b397-14b0624258c5 | ||
| 938 | |a YBP Library Services |b YANK |n 12618776 | ||
| 994 | |a 92 |b IZTAP | ||